TARPLIN, DOWNS & YOUNG, LLC

Lobbying for MERCK · A research-intensive biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Budget/Appropriations

Federal budget issues

Health Issues

IRA, innovation, drug pricing in federal programs, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars, PAHPA

Medicare/Medicaid

IRA, Medicare and Medicaid payment and coverage issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.